BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pan L, Jia ZS, Chen L, Fu EQ, Li GY. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus. World J Gastroenterol 2005; 11(16): 2518-2521 [PMID: 15832429 DOI: 10.3748/wjg.v11.i16.2518]
URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2518.htm
Number Citing Articles
1
Huang Wen, Ju Jintao, Fan Qunming, Xiao Lining, Li Zhaoshen. Challenges and prospects in research on military epidemiologyJournal of Medical Colleges of PLA 2010; 25(3): 129 doi: 10.1016/S1000-1948(10)60031-7
2
V. V. Dantsev, R. D. Muchaidze, L. R. Levina, M. G. Spitsyn, V. S. Tokmakov, G. S. Balasanyants. The impact of the infection caused by hepatitis B and C on the characteristics of hepatotoxic reactions in tuberculosis patientsTuberculosis and Lung Diseases 2020; 98(7): 26 doi: 10.21292/2075-1230-2020-98-7-26-30
3
G. Shelton McMullan, James H. Lewis, David Schlossberg. Tuberculosis of the Liver, Biliary Tract, and PancreasMicrobiology Spectrum 2017; 5(1) doi: 10.1128/microbiolspec.TNMI7-0025-2016
4
Axel Cyriaque Ambassa, Lionel Ulrich Tiani, Ngounoue Marceline Djuidje, Assam Jean Paul Assam, Généviève Andoseh, Thiomo Diane Kamdem, Fossi Cédric Tchinda, Numfor Leonard Nkah, Kamga Hortense Gonsu, Charles kouanfack, Yone Eric Walter Pefura, Francine Ntoumi, Beng Véronique Penlap. Liver enzyme evaluation and NAT2 polymorphism in patients on anti-tuberculosis and antiretroviral drugs at Jamot Hospital in Yaound-CameroonAfrican Journal of Biotechnology 2022; 21(3): 106 doi: 10.5897/AJB2021.17436
5
Tume Christopher Bonglavnyuy. Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western CameroonGlobal Journal of Infectious Diseases and Clinical Research 2017; : 001 doi: 10.17352/2455-5363.000011
6
Chawin Sirinak, Wanitchaya Kittikraisak, Duangporn Pinjeesekikul, Pricha Charusuntonsri, Phinai Luanloed, La-ong Srisuwanvilai, Sriprapa Nateniyom, Somsak Akksilp, Sirirat Likanonsakul, Wanchai Sattayawuthipong, Channawong Burapat, Jay K Varma. Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in ThailandBMC Public Health 2008; 8(1) doi: 10.1186/1471-2458-8-245
7
Mark H. Kuniholm, Jennifer Mark, Malvina Aladashvili, N. Shubladze, G. Khechinashvili, Tengiz Tsertsvadze, Carlos del Rio, Kenrad E. Nelson. Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patientsInternational Journal of Infectious Diseases 2008; 12(1): 51 doi: 10.1016/j.ijid.2007.04.015
8
Thomas H. Taylor, Dalia Ibrahim, James H. Lewis. Tuberculosis and Nontuberculous Mycobacterial Infections2021; : 372 doi: 10.1128/9781555817138.ch25
9
Christina Chou, Nicolette Veracruz, Amit S. Chitnis, Robert J. Wong. Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysisJournal of Viral Hepatitis 2022; 29(12): 1107 doi: 10.1111/jvh.13751
10
Jiangshan Lian, Ping Hu, Yingfeng Lu, Yueying Liu, Xiaoxiao Wang, Yimin Zhang, Hongyu Jia, Yida Yang. Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virusVirus Research 2019; 270: 197664 doi: 10.1016/j.virusres.2019.197664
11
G. Shelton McMullan, James H. Lewis. Tuberculosis and Nontuberculous Mycobacterial Infections2017; : 439 doi: 10.1128/9781555819866.ch27
12
Amir F Khan, Ahsan Sajjad, Dedaar A Mian, Muhammad M Tariq, Usman K Jadoon, Muhammad Abbas, Kinza Shakeel, Nadia Saeed, Kiran Abbas. Co-infection With Hepatitis B in Tuberculosis Patients on Anti-tuberculosis Treatment and the Final OutcomeCureus 2021;  doi: 10.7759/cureus.14433
13
Chun-hui Zhu, Man-zhi Zhao, Guang Chen, Jun-ying Qi, Jian-xin Song, Qin Ning, Dong Xu. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosisJournal of Huazhong University of Science and Technology [Medical Sciences] 2017; 37(1): 105 doi: 10.1007/s11596-017-1702-3
14
Maria de Fátima Silva de Lima, Heloísa Ramos Lacerda de Melo. Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosisCadernos de Saúde Pública 2012; 28(4): 698 doi: 10.1590/S0102-311X2012000400009
15
Lubiao Chen, Dujing Bao, Lin Gu, Yurong Gu, Liang Zhou, Zhiliang Gao, Yuehua Huang. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatmentBMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3192-8
16
G. BUSHNELL, N. L. STENNIS, A. M. DROBNIK, D. C. PROOPS, S. D. AHUJA, K. BORNSCHLEGEL, J. FULD. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010Epidemiology and Infection 2015; 143(9): 1972 doi: 10.1017/S0950268814002970
17
Jing Zheng, Mei-Hong Guo, He-Wei Peng, Xiao-Ling Cai, Yun-Li Wu, Xian-E Peng. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studiesEpidemiology and Infection 2020; 148 doi: 10.1017/S0950268820002861
18
Getnet Yimer, Getachew Aderaye, Wondwossen Amogne, Eyasu Makonnen, Eleni Aklillu, Lars Lindquist, Lawrence Yamuah, Beniyam Feleke, Abraham Aseffa, Landon Myer. Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative PatientsPLoS ONE 2008; 3(3): e1809 doi: 10.1371/journal.pone.0001809
19
Ning-Tao Wang, Yi-Shin Huang, Meng-Hsien Lin, Bryan Huang, Chin-Lin Perng, Han-Chieh Lin. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysisJournal of the Chinese Medical Association 2016; 79(7): 368 doi: 10.1016/j.jcma.2015.12.006
20
Mohammed A. Agha, Ibraheim I. El-Mahalawy, Hosam M. Seleem, Mohamed A. Helwa. Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicityEgyptian Journal of Chest Diseases and Tuberculosis 2015; 64(1): 91 doi: 10.1016/j.ejcdt.2014.09.009
21
Successful Treatment of HCV/TB co-infected Patient With Sofosbuvir and Daclatasvir: A Case ReportFuture Virology 2018; 13(5): 317 doi: 10.2217/fvl-2017-0141
22
Wan Beom Park, Won Kim, Kook Lae Lee, Jae-Joon Yim, Moonsuk Kim, Yong Jin Jung, Nam Joong Kim, Dong Hee Kim, Yoon Jun Kim, Jung-Hwan Yoon, Myoung-don Oh, Hyo Suk Lee. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosisJournal of Infection 2010; 61(4): 323 doi: 10.1016/j.jinf.2010.07.009